Using a laser treatment to help improve gum disease management
Official title: An Evaluation of the Effect of the Erchonia Corporation FX-405 Laser as an Adjunctive Treatment of Periodontitis
Run by Erchonia Corporation · NCT06656325 · Data updated 2026-11-12
This study is testing if a special laser treatment can help improve the results of regular gum disease care for people receiving standard dental cleaning.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 22 Years to 75 Years |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | Erchonia Corporation Industry-sponsored |
| Locations | 2 sites (Thousand Oaks, California and 1 other locations) |
| Status | Recruiting |
| Started | January 1, 2025 |
| Main results expected | June 1, 2027 |
| Study ends | August 1, 2027 |
| Registry record updated | May 18, 2026 |
| Trial ID | NCT06656325 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 22 to 75 with mild to moderate periodontitis and limited tooth loss.
✕Probably not a fit
Patients with localized aggressive periodontitis or significant prior periodontal surgery may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical study evaluates the effectiveness of the Erchonia® FX-405 laser as a noninvasive adjunctive treatment for periodontal disease when combined with standard periodontal scaling and root planing. The study employs a double-blind design, ensuring that neither participants nor investigators know who receives the active treatment versus a sham treatment until the study concludes. All participants will receive the standard care of scaling and root planing, alongside either the active laser treatment or a placebo. The goal is to determine if the laser can enhance the outcomes of traditional gum disease treatments.
Why it matters
Potential benefit: If successful, this treatment could provide a more effective option for managing periodontal disease, potentially leading to better oral health outcomes.
How similar studies have gone: While the use of lasers in periodontal treatment is gaining interest, this specific approach with the Erchonia FX-405 is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subject has voluntarily signed a written informed consent form. * Male or female 22 to 75 years of age, inclusive. * Subject has no evidence of Localized Aggressive Periodontitis. * Tooth loss due to periodontitis of ≤ 4 teeth. * Two or more teeth with the following characteristics: Non 3rd molar, Periodontitis: Stage III (Severity) according to the Interdental CAL (at site of greatest loss) and RBL, as classified by the American Academy of Periodontology (AAP), No evidence of caries, No abscess infection, No previous periodontal surgery within the prior 12 months * Subject agrees to adhere to study provided home care instructions to maintain adequate oral hygiene during the study duration. * Subject agrees to refrain from the use of smokeless chewing tobacco for the study duration. * Subject agrees to refrain from exceeding 40 milligrams per day of inhaled nicotine, encompassing cigarettes, electronic cigarettes, and cigars. * Subject agrees to refrain from engaging in any other treatments for his or her periodontitis that is outside the scope of this study during his or her participation in this study Exclusion Criteria: * Gingival recession which may be genetic, induced secondary to orthodontic treatment, induced secondary to frenulum attachments, or present as a result of dental malocclusion. * History of oral cancer or HIV in the last 6 months * Pregnant or intending to become pregnant in the next 8 months. * Sensitivity to, or contraindication for, light therapy. * Currently enrolled in a clinical study of an investigational drug or device.
Where it's running
-
805 Dentistry
Thousand Oaks, California, United States Recruiting -
Acton Dental Associates
Acton, Massachusetts, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if periodontal treatment improves chewing ability and oral quality of life
This study tests whether treating periodontitis improves how well people can chew and how they feel about their oral health.
-
Candida albicans and periodontitis in Syrian patients
This project will test whether Candida albicans is commonly present in the gum pockets of Syrian adults with chronic periodontitis.
-
JAK1 and JAK2 activation in healthy versus inflamed gums
We will test whether the JAK1 and JAK2 immune-signaling pathways are more active in adults with periodontitis than in adults with healthy gums.
-
Online self-check to identify your gum disease risk and guide preventive care
This project will test whether an online questionnaire can accurately identify gum disease risk in adults with natural teeth.
-
Blood and saliva markers to track gum disease and healing after non-surgical cleaning
This project tries to see if a blood score (HALP), other blood inflammation markers, and salivary MMP-8 can help identify gum disease stage and predict healing after non-surgical periodontal cleaning in adults aged 18–65.
-
Lovastatin gel under the gum plus deep cleaning for periodontitis in smokers and non-smokers
This test sees if placing a 1.2% lovastatin gel under the gum after deep cleaning helps adults with periodontitis, comparing smokers and non-smokers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.